A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants

NCT07214766 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Trastuzumab

Sponsor

Genentech, Inc.